Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev …
WEB5 days ago · SAN DIEGO, September 19, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control ...
TNDM Stock Likely to Gain From Innovation Amid Competition
WEB1 day ago · Estimates for TransMedics’ 2024 earnings per share (EPS) have moved up 2.5% to $1.23 in the past 30 days. Shares of the company have soared 156.5% in the past year compared with the industry’s ...
Tandem Diabetes rises as insulin pump cleared for use in EU with …
WEBTandem Diabetes Care (NASDAQ:TNDM) is up ~3% in Thursday midday trading after its t:slim X2 insulin pump was cleared for use with Eli Lilly's (NYSE:LLY) ultra-rapid acting insulin Lyumjev (insulin ...
Tandem Diabetes Care to Present New Early User Insights on the Tandem …
WEBSAN DIEGO, June 18, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for the American...
More than 200 people with diabetes injured after software issue ... - CNN
WEBMay 8, 2024 · More than 200 people with diabetes have been injured when their insulin pumps shut down unexpectedly due to a problem with a connected mobile app, the US Food and Drug Administration said Wednesday.
News Release - Tandem Diabetes Care
WEBJun 30, 2024 · Worldwide GAAP sales increased 13 percent to $221.9 million compared to second quarter 2023; worldwide non-GAAP sales (1) increased 12 percent to $221.8 million compared to second quarter 2023. More than 20,000 pumps shipped in the United States, a sequential increase of 33 percent compared to first quarter 2024.
Faulty insulin pump tech led to hundreds of injuries ... - CBS News
WEBMay 9, 2024 · The software glitch has prompted the recall of more than 85,000 versions of a mobile app, called t:connect and developed by Tandem Diabetes Care, the FDA noted on Wednesday.
News Release - Tandem Diabetes Care
WEBSAN DIEGO -- (BUSINESS WIRE)--Dec. 12, 2023-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs).
News Release - Tandem Diabetes Care
WEBTandem Mobi is a new way for people living with diabetes to experience the life-changing benefits of Control-IQ technology, the same technology that helped make Tandem the #1 recommended pump brand. 1 The Control-IQ advanced hybrid closed-loop automated insulin delivery feature, cleared for use by people with type 1 diabetes age 6 and up ...
Tandem gets approval for t:slim X2 pump to use with Lyumjev
WEB4 days ago · Tandem Diabetes Care has announced that its t:slim X2 insulin pump, featuring Control-IQ automated insulin delivery technology, received approval for use with the ultra-rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) from Eli Lilly, in the European Union (EU). This clearance follows the EU’s general authorisation of …
Skip to content